Philip J. Y. Leung

Philip J. Y. Leung

Auto-generated profile, based on publicly available information

Philip J. Y. Leung

Department of Biochemistry, University of Washington

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Nature
Verified
Journal Article
Open access
PDF file
NBNathaniel R. Bennett
Nathaniel R. Bennett
JWJoseph L. Watson
Joseph L. Watson
RRRobert J. Ragotte
Robert J. Ragotte
ABAndrew J. Borst
Andrew J. Borst
DSDéjenaé L. See
Déjenaé L. See
DBDavid Baker
David Baker
Despite the central role of antibodies in modern medicine, no method currently exists to design novel, epitope-specific antibodies entirely in silico. Instead, antibody discovery currently relies on immunization, random library screening or the isolation of antibodies directly from patients1. Here we demonstrate that combining computational protein design using a fine-tuned RFdiffusion2 network with yeast display screening enables the de novo generation of antibody variable heavy chains (VHHs), single-chain variable fragments (scFvs) and full antibodies that bind to user-specified epitopes with atomic-level precision. We experimentally characterize VHH binders to four disease-relevant epitopes. Cryo-electron microscopy confirms the binding pose of designed VHHs targeting influenza haemagglutinin and Clostridium difficile toxin B (TcdB). A high-resolution structure of the influenza-targeting VHH confirms atomic accuracy of the designed complementarity-determining regions (CDRs). Although initial computational designs exhibit modest affinity (tens to hundreds of nanomolar Kd), affinity maturation using OrthoRep3 enables production of single-digit nanomolar binders that maintain the intended epitope selectivity. We further demonstrate the de novo design of scFvs to TcdB and a PHOX2B peptide–MHC complex by combining designed heavy-chain and light-chain CDRs. Cryo-electron microscopy confirms the binding pose for two distinct TcdB scFvs, with high-resolution data for one design verifying the atomically accurate design of the conformations of all six CDR loops. Our approach establishes a framework for the computational design, screening and characterization of fully de novo antibodies with atomic-level precision in both structure and epitope targeting.

18 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNathaniel R. Bennett
Nathaniel R. Bennett
JWJoseph L. Watson
Joseph L. Watson
RRRobert J. Ragotte
Robert J. Ragotte
ABAndrew J. Borst
Andrew J. Borst
DSDéjenaé L. See
Déjenaé L. See
DBDavid Baker
David Baker
Despite the central role that antibodies play in modern medicine, there is currently no method to design novel antibodies that bind a specific epitope entirely in silico . Instead, antibody discovery currently relies on animal immunization or random library screening approaches. Here, we demonstrate that combining computational protein design using a fine-tuned RFdiffusion network alongside yeast display screening enables the generation of antibody variable heavy chains (VHHs) and single chain variable fragments (scFvs) that bind user-specified epitopes with atomic-level precision. To verify this, we experimentally characterized VHH binders to four disease-relevant epitopes using multiple orthogonal biophysical methods, including cryo-EM, which confirmed the proper Ig fold and binding pose of designed VHHs targeting influenza hemagglutinin and Clostridium difficile toxin B (TcdB). For the influenza-targeting VHH, high-resolution structural data further confirmed the accuracy of CDR loop conformations. While initial computational designs exhibit modest affinity, affinity maturation using OrthoRep enables production of single-digit nanomolar binders that maintain the intended epitope selectivity. We further demonstrate the de novo design of single-chain variable fragments (scFvs), creating binders to TcdB and a Phox2b peptide-MHC complex by combining designed heavy and light chain CDRs. Cryo-EM structural data confirmed the proper Ig fold and binding pose for two distinct TcdB scFvs, with high-resolution data for one design additionally verifying the atomically accurate conformations of all six CDR loops. Our approach establishes a framework for the rational computational design, screening, isolation, and characterization of fully de novo antibodies with atomic-level precision in both structure and epitope targeting.

18 August 2023 in Science
Verified
Journal Article
Open access
FPFlorian Praetorius
Florian Praetorius
PLPhilip J. Y. Leung
Philip J. Y. Leung
MTMaxx H. Tessmer
Maxx H. Tessmer
ABAdam Broerman
Adam Broerman
CDCullen Demakis
Cullen Demakis
DBDavid Baker
David Baker
In nature, proteins that switch between two conformations in response to environmental stimuli structurally transduce biochemical information in a manner analogous to how transistors control information flow in computing devices. Designing proteins with two distinct but fully structured conformations is a challenge for protein design as it requires sculpting an energy landscape with two distinct minima. Here we describe the design of “hinge” proteins that populate one designed state in the absence of ligand and a second designed state in the presence of ligand. X-ray crystallography, electron microscopy, double electron-electron resonance spectroscopy, and binding measurements demonstrate that despite the significant structural differences the two states are designed with atomic level accuracy and that the conformational and binding equilibria are closely coupled.

4 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JDJ. Dauparas
J. Dauparas
IAI. Anishchenko
I. Anishchenko
NBN. Bennett
N. Bennett
HBH. Bai
H. Bai
RRR. J. Ragotte
R. J. Ragotte
DBD. Baker
D. Baker
While deep learning has revolutionized protein structure prediction, almost all experimentally characterized de novo protein designs have been generated using physically based approaches such as Rosetta. Here we describe a deep learning based protein sequence design method, ProteinMPNN, with outstanding performance in both in silico and experimental tests. The amino acid sequence at different positions can be coupled between single or multiple chains, enabling application to a wide range of current protein design challenges. On native protein backbones, ProteinMPNN has a sequence recovery of 52.4%, compared to 32.9% for Rosetta. Incorporation of noise during training improves sequence recovery on protein structure models, and produces sequences which more robustly encode their structures as assessed using structure prediction algorithms. We demonstrate the broad utility and high accuracy of ProteinMPNN using X-ray crystallography, cryoEM and functional studies by rescuing previously failed designs, made using Rosetta or AlphaFold, of protein monomers, cyclic homo-oligomers, tetrahedral nanoparticles, and target binding proteins. One-sentence summary: A deep learning based protein sequence design method is described that is widely applicable to current design challenges and shows outstanding performance in both in silico and experimental tests.

10 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
STSusana Vázquez Torres
Susana Vázquez Torres
PLPhilip J. Y. Leung
Philip J. Y. Leung
ILIsaac D. Lutz
Isaac D. Lutz
PVPreetham Venkatesh
Preetham Venkatesh
JWJoseph L. Watson
Joseph L. Watson
DBDavid Baker
David Baker
Many peptide hormones form an alpha-helix upon binding their receptors 1–4 , and sensitive detection methods for them could contribute to better clinical management. De novo protein design can now generate binders with high affinity and specificity to structured proteins 5,6 . However, the design of interactions between proteins and short helical peptides is an unmet challenge. Here, we describe parametric generation and deep learning-based methods for designing proteins to address this challenge. We show that with the RF diffusion generative model, picomolar affinity binders can be generated to helical peptide targets either by noising and then denoising lower affinity designs generated with other methods, or completely de novo starting from random noise distributions; to our knowledge these are the highest affinity designed binding proteins against any protein or small molecule target generated directly by computation without any experimental optimization. The RF diffusion designs enable the enrichment of parathyroid hormone or other bioactive peptides in human plasma and subsequent detection by mass spectrometry, and bioluminescence-based protein biosensors. Capture reagents for bioactive helical peptides generated using the methods described here could aid in the improved diagnosis and therapeutic management of human diseases. 7,8

2 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
APArvind Pillai
Arvind Pillai
AIAbbas Idris
Abbas Idris
APAnnika Philomin
Annika Philomin
CWConnor Weidle
Connor Weidle
RSRebecca Skotheim
Rebecca Skotheim
DBDavid Baker
David Baker
Allosteric modulation of protein function, wherein the binding of an effector to a protein triggers conformational changes at distant functional sites, plays a central role in the control of metabolism and cell signaling 1–3 . There has been considerable interest in designing allosteric systems, both to gain insight into the mechanisms underlying such “action at a distance” modulation and to create synthetic proteins whose functions can be regulated by effectors 4–7 . However, emulating the subtle conformational changes distributed across many residues, characteristic of natural allosteric proteins, is a significant challenge 8,9 . Here, inspired by the classic Monod-Changeux-Wyman model of cooperativity 10 , we investigate the de novo design of allostery through rigid-body coupling of designed effector-switchable hinge modules 11 to protein interfaces 12 that direct the formation of alternative oligomeric states. We find that this approach can be used to generate a wide variety of allosterically switchable systems, including cyclic rings that incorporate or eject subunits in response to effector binding and dihedral cages that undergo effector-induced disassembly. Size-exclusion chromatography, mass photometry 13 , and electron microscopy reveal that these designed allosteric protein assemblies closely resemble the design models in both the presence and absence of effectors and can have ligand-binding cooperativity comparable to classic natural systems such as hemoglobin 14 . Our results indicate that allostery can arise from global coupling of the energetics of protein substructures without optimized sidechain-sidechain allosteric communication pathways and provide a roadmap for generating allosterically triggerable delivery systems, protein nanomachines, and cellular feedback control circuitry.